Source link : https://www.newshealth.biz/health-news/empagliflozin-linked-to-lower-risk-of-diabetic-retinopathy-progression/
Use of empagliflozin (Jardiance) was not linked to a lower risk of incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with type 2 diabetes, but the SGLT2 inhibitor was associated with a lower risk of diabetic retinopathy progression, an active-comparator cohort study suggested. Among 34,239 matched pairs, the risk of incident […]
Author : News Health
Publish date : 2024-12-05 17:13:49
Copyright for syndicated content belongs to the linked Source.